These observations may imply that the locus, spanning chromosome 8q23.13-q24.21 is a strong driver for SQLE expression in breast and ovarian cancer, explaining a relevant proportion of its variability across samples, whereas possibly other variables, in addition to copy dosage, may concur in determining MYC transcriptional levels in those two cancers. Here, MYC is linked to ovarian cancer.